Trisomy X syndrome

Trisomy X syndrome, also known as Triple X syndrome or 47,XXX, is a chromosomal condition that occurs in females who have three X chromosomes instead of the usual two. It is one of the most common sex chromosome aneuploidies, arising from nondisjunction during meiosis or early post-zygotic mitotic division. Many affected individuals are never diagnosed because the condition can present with mild or no obvious symptoms. Trisomy X can affect multiple body systems, though the severity varies widely. Common features include tall stature, which often becomes apparent in childhood, and a tendency toward learning difficulties, particularly in speech and language development. Some individuals experience mild delays in motor skill development. Behavioral and emotional challenges, including anxiety and attention difficulties, may occur. Clinodactyly (curved fifth fingers) and epicanthal folds are occasionally noted. Most females with Trisomy X have normal sexual development and fertility, though some may experience premature ovarian insufficiency. Rarely, genitourinary or renal anomalies may be present. There is no cure for Trisomy X syndrome, and management is supportive and symptom-based. Early intervention services, including speech therapy, occupational therapy, and educational support, can significantly improve developmental outcomes. Psychological support may be beneficial for those experiencing emotional or behavioral difficulties. Hormonal evaluation may be warranted if there are concerns about pubertal development or fertility. Regular developmental monitoring throughout childhood is recommended. With appropriate support, most individuals with Trisomy X lead healthy, independent lives.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Trisomy X syndrome